HYUNDAI BIOLAND Co.Ltd
HYUNDAI BIOLAND Co.,Ltd manufactures and sells raw materials for cosmetics, nutraceuticals, and regenerative medicines. It offers anti-aging, moisturizing, whitening, skin protection, and other cosmetic ingredients; functional food ingredients and general food raw materials; and active pharmaceutical ingredients. The company was formerly known as SKbioland Co., Ltd. and changed its name to HYUNDA… Read more
HYUNDAI BIOLAND Co.Ltd (052260) - Total Assets
Latest total assets as of September 2025: ₩165.86 Billion KRW
Based on the latest financial reports, HYUNDAI BIOLAND Co.Ltd (052260) holds total assets worth ₩165.86 Billion KRW as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
HYUNDAI BIOLAND Co.Ltd - Total Assets Trend (2011–2024)
This chart illustrates how HYUNDAI BIOLAND Co.Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
HYUNDAI BIOLAND Co.Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
HYUNDAI BIOLAND Co.Ltd's total assets of ₩165.86 Billion consist of 55.0% current assets and 45.0% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩21.01 Billion | 10.8% |
| Accounts Receivable | ₩13.02 Billion | 6.7% |
| Inventory | ₩57.40 Billion | 29.5% |
| Property, Plant & Equipment | ₩67.03 Billion | 34.4% |
| Intangible Assets | ₩2.11 Billion | 1.1% |
| Goodwill | ₩1.73 Billion | 0.9% |
Asset Composition Trend (2011–2024)
This chart illustrates how HYUNDAI BIOLAND Co.Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: HYUNDAI BIOLAND Co.Ltd's current assets represent 55.0% of total assets in 2024, an increase from 0.0% in 2011.
- Cash Position: Cash and equivalents constituted 10.8% of total assets in 2024, up from 7.4% in 2011.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, unchanged from 1.0% in 2011.
- Asset Diversification: The largest asset category is property, plant & equipment at 34.4% of total assets.
HYUNDAI BIOLAND Co.Ltd Competitors by Total Assets
Key competitors of HYUNDAI BIOLAND Co.Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Globon Co. Ltd
KQ:019660
|
Korea | ₩20.12 Billion |
|
Gentrogroup Co. Ltd.
KQ:083660
|
Korea | ₩34.38 Billion |
|
NeoPharm CO. LTD
KQ:092730
|
Korea | ₩207.38 Billion |
|
Auxilia SA
WAR:AUX
|
Poland | zł45.57 Million |
|
Nextbike Polska SA
WAR:NXB
|
Poland | zł60.52 Million |
|
464680
KQ:464680
|
Korea | ₩31.23 Billion |
|
Kukyoung G&M
KO:006050
|
Korea | ₩71.75 Billion |
HYUNDAI BIOLAND Co.Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - HYUNDAI BIOLAND Co.Ltd generates 0.61x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, HYUNDAI BIOLAND Co.Ltd generates $ 2.93 in net profit.
HYUNDAI BIOLAND Co.Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.51 | 1.93 | 1.53 |
| Quick Ratio | 1.63 | 0.90 | 0.71 |
| Cash Ratio | 0.00 | 0.43 | 0.00 |
| Working Capital | ₩64.87 Billion | ₩ 43.24 Billion | ₩ 18.94 Billion |
HYUNDAI BIOLAND Co.Ltd - Advanced Valuation Insights
This section examines the relationship between HYUNDAI BIOLAND Co.Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.88 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 5.8% |
| Total Assets | ₩194.73 Billion |
| Market Capitalization | $27.04 Million USD |
Valuation Analysis
Below Book Valuation: The market values HYUNDAI BIOLAND Co.Ltd's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: HYUNDAI BIOLAND Co.Ltd's assets grew by 5.8% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for HYUNDAI BIOLAND Co.Ltd (2011–2024)
The table below shows the annual total assets of HYUNDAI BIOLAND Co.Ltd from 2011 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ₩194.73 Billion | +5.79% |
| 2023-12-31 | ₩184.07 Billion | +4.53% |
| 2022-12-31 | ₩176.10 Billion | +1.94% |
| 2021-12-31 | ₩172.74 Billion | -7.95% |
| 2020-12-31 | ₩187.66 Billion | -10.23% |
| 2019-12-31 | ₩209.05 Billion | +8.23% |
| 2018-12-31 | ₩193.16 Billion | +9.52% |
| 2017-12-31 | ₩176.37 Billion | +5.19% |
| 2016-12-31 | ₩167.67 Billion | +9.33% |
| 2015-12-31 | ₩153.36 Billion | +7.13% |
| 2014-12-31 | ₩143.16 Billion | +0.44% |
| 2013-12-31 | ₩142.53 Billion | -3.08% |
| 2012-12-31 | ₩147.06 Billion | +14.13% |
| 2011-12-31 | ₩128.86 Billion | -- |